Tower Research Capital (TRC)’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,698
Closed -$26K 7132
2021
Q4
$26K Buy
16,698
+4,108
+33% +$6.78K ﹤0.01% 3406
2021
Q3
$20K Buy
12,590
+8,467
+205% +$16.6K ﹤0.01% 3739
2021
Q2
$11K Sell
4,123
-20,603
-83% -$38.4K ﹤0.01% 4358
2021
Q1
$37K Buy
24,726
+5,050
+26% +$8.76K ﹤0.01% 3388
2020
Q4
$26K Buy
+19,676
New +$22.1K ﹤0.01% 3707
2020
Q3
Sell
-44,169
Closed -$37K 5258
2020
Q2
$37K Buy
44,169
+37,830
+597% +$28.1K ﹤0.01% 3296
2020
Q1
$5K Sell
6,339
-29,219
-82% -$32.6K ﹤0.01% 2333
2019
Q4
$47K Buy
35,558
+9,293
+35% +$13K ﹤0.01% 1382
2019
Q3
$37K Buy
26,265
+24,380
+1,293% +$48.6K ﹤0.01% 2019
2019
Q2
$6K Sell
1,885
-10,013
-84% -$34.5K ﹤0.01% 2898
2019
Q1
$44K Sell
11,898
-2,236
-16% -$7.1K ﹤0.01% 1835
2018
Q4
$31K Sell
14,134
-13,214
-48% -$32.8K ﹤0.01% 1618
2018
Q3
$73K Buy
27,348
+26,878
+5,719% +$95K 0.01% 1539
2018
Q2
$2K Sell
470
-19,114
-98% -$71.8K ﹤0.01% 3408
2018
Q1
$71K Buy
19,584
+5,394
+38% +$20K 0.01% 1478
2017
Q4
$53K Buy
14,190
+13,556
+2,138% +$54.3K 0.01% 1311
2017
Q3
$3K Buy
634
+179
+39% +$737 ﹤0.01% 3512
2017
Q2
$2K Sell
455
-5,785
-93% -$22.6K ﹤0.01% 2405
2017
Q1
$22K Buy
6,240
+621
+11% +$2.18K ﹤0.01% 1256
2016
Q4
$28K Buy
+5,619
New +$25.5K ﹤0.01% 1854
2016
Q3
Sell
-8,220
Closed -$32K 4757
2016
Q2
$32K Buy
8,220
+6,370
+344% +$25K ﹤0.01% 1889
2016
Q1
$6K Buy
+1,850
New +$6.08K ﹤0.01% 2591
2015
Q4
Sell
-7,159
Closed -$30K 5265
2015
Q3
$30K Buy
7,159
+6,759
+1,690% +$42.6K ﹤0.01% 1407
2015
Q2
$3K Sell
400
-10,627
-96% -$88.6K ﹤0.01% 3602
2015
Q1
$86K Buy
11,027
+9,290
+535% +$79.5K 0.01% 1021
2014
Q4
$20K Sell
1,737
-4,939
-74% -$59K ﹤0.01% 1607
2014
Q3
$86K Sell
6,676
-32,372
-83% -$427K 0.01% 1097
2014
Q2
$593K Buy
39,048
+32,716
+517% +$532K 0.08% 207
2014
Q1
$134K Buy
+6,332
New +$183K 0.02% 569

Tower Research Capital (TRC)'s CSLT Position: Q1 2022 in Review

Tower Research Capital (TRC) sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 16,698 shares — an estimated $26K sold.

Tower Research Capital (TRC) first reported a position in CSLT in Q1 2014 and held it in 29 quarters. The position peaked at $593K in Q2 2014. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

  • Tower Research Capital (TRC) reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 16,698 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $26K.
  • Tower Research Capital (TRC) first reported a position in CASTLIGHT HEALTH, INC. in Q1 2014 and held it in 29 quarters.
  • Tower Research Capital (TRC)'s CASTLIGHT HEALTH, INC. position peaked at $593K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.